Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the involvement of individual JAK kinases in the realization of the growth potential of mesenchymal precursors under the effect of fibroblast growth factor. The important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells and participation of JAK1 in this process under conditions of cytokine stimulation of progenitor cells were demonstrated. Specific inhibitors of these kinases reduced the yield of fibroblast CFU and the rate of their division. Moreover, blockade of JAK1, JAK2, and JAK3 under the effect of fibroblast growth factor was accompanied by an increase in the intensity of progenitor cell differentiation.

About the authors

G. N. Zyuz’kov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Author for correspondence.
Email: zgn@pharmso.ru
Russian Federation, Tomsk; Tomsk

V. V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

E. V. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

L. A. Miroshnichenko

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

E. V. Simanina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

T. Yu. Polyakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

L. A. Stavrova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

V. V. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Email: zgn@pharmso.ru
Russian Federation, Tomsk; Tomsk

M. Yu. Minakova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk

A. M. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharmso.ru
Russian Federation, Tomsk


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies